SCHEMBL670658

SCHEMBL670658

COc1ccccc1C#CC(=O)O

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FFAR1 O14842 1/20 0.52
PTGDR2 Q9Y5Y4 2/20 0.49
GRM5 P41594 1/20 0.46
CA1 P00915 3/20 0.46
CA2 P00918 3/20 0.46
CA12 O43570 2/20 0.46
CA7 P43166 2/20 0.46
CA9 Q16790 2/20 0.46
CA14 Q9ULX7 2/20 0.46
POLB P06746 2/20 0.44
SMN1; SMN2 Q16637 1/20 0.44
NPC1 O15118 1/20 0.44
HTT P42858 2/20 0.43
KMT2A Q03164 2/20 0.43
CA4 P22748 1/20 0.43
NPSR1 Q6W5P4 1/20 0.42
L3MBTL1 Q9Y468 1/20 0.42
HSP90AA1 P07900 1/20 0.42
NTSR1 P30989 1/20 0.42
LMNA P02545 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18104885 0.87 FFAR1 (0.50) FFAR1PTGDR2GRM5CA1CA2
SCHEMBL8195398 0.85 FFAR1 (0.49) FFAR1PTGDR2GRM5CA1CA2
SCHEMBL27167227 0.84 HSP90AA1 (0.63) FFAR1PTGDR2GRM5CA1CA2
SCHEMBL3826877 0.84 CA12 (0.46) FFAR1PTGDR2CA1CA2CA12
SCHEMBL459924 0.84 FFAR1 (0.48) FFAR1PTGDR2GRM5CA1CA2
SCHEMBL2292901 0.82 PTGDR2 (0.46) FFAR1PTGDR2POLBSMN1; SMN2NPC1
SCHEMBL20089252 0.81 FFAR1 (0.46) FFAR1PTGDR2GRM5CA1CA2
SCHEMBL12469659 0.81 L3MBTL1 (0.53) PTGDR2POLBKMT2ANPSR1L3MBTL1
SCHEMBL30059262 0.80 RAB9A (0.57) FFAR1PTGDR2POLBSMN1; SMN2NPC1
SCHEMBL4214499 0.80 CA1 (0.60) FFAR1PTGDR2GRM5CA1CA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-103254236-A Preparation method of 4-aryl coumarin-3-phosphonate derivatives UNIV SOOCHOW 2013-08-21 CN claimed
CN-118084727-A Method for preparing nitrile by catalyzing electron-deficient alkene or alkyne through heterogeneous metal manganese catalyst 中国科学院大连化学物理研究所 2024-05-28 CN disclosed
EP-2606025-B1 PROCESS FOR PREPARING A PROPIOLIC ACID OR A DERIVATIVE THEREOF BASF SE (DE) 2016-10-12 EP disclosed
US-9174984-B2 Chemical compounds GLAXOSMITHKLINE INTELLECTUAL PROPERTY (NO.2) LIMITED (GB) 2015-11-03 US disclosed
US-9174984-B2 Chemical compounds GLAXOSMITHKLINE INTELLECTUAL PROPERTY (NO.2) LIMITED (GB) 2015-11-03 US disclosed
US-9073844-B2 Process for preparing a propiolic acid or a derivative thereof BASF SE (DE) 2015-07-07 US disclosed
US-20140296204-A1 CHEMICAL COMPOUNDS GLAXOSMITHKLINE INTELLECTUAL PROPERTY (NO.2) LIMITED (GB) 2014-10-02 US disclosed
US-20140296204-A1 CHEMICAL COMPOUNDS GLAXOSMITHKLINE INTELLECTUAL PROPERTY (NO.2) LIMITED (GB) 2014-10-02 US disclosed
US-20140012000-A1 PROCESS FOR PREPARING A PROPIOLIC ACID OR A DERIVATIVE THEREOF BASF SE (DE) 2014-01-09 US disclosed
CN-103254236-A Preparation method of 4-aryl coumarin-3-phosphonate derivatives UNIV SOOCHOW 2013-08-21 CN disclosed
EP-2606025-A1 PROCESS FOR PREPARING A PROPIOLIC ACID OR A DERIVATIVE THEREOF BASF SE (DE) 2013-06-26 EP disclosed
WO-2013062945-A1 CHEMICAL COMPOUNDS GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED (GB) 2013-05-02 WO disclosed
EP-2571835-A2 PROCESS FOR THE PRODUCTION OF FLUORINATED ALKENES Honeywell International, Inc. (US) 2013-03-27 EP disclosed
WO-2012022801-A1 PROCESS FOR PREPARING A PROPIOLIC ACID OR A DERIVATIVE THEREOF TECHNISCHE UNIVERSITÄT KAISERSLAUTERN (DE) 2012-02-23 WO disclosed
WO-2011146802-A2 PROCESS FOR THE PRODUCTION OF FLUORINATED ALKENES HONEYWELL INTERNATIONAL INC. (US) 2011-11-24 WO disclosed
EP-2310347-A2 PROCESS FOR THE PREPARATION OF PERFLUORINATED CIS-ALKENE Honeywell International Inc. (US) 2011-04-20 EP disclosed
WO-2010014548-A2 PROCESS FOR THE PREPARATION OF PERFLUORINATED CIS-ALKENE HONEYWELL INTERNATIONAL INC. (US) 2010-02-04 WO disclosed
US-6569600-B2 Optical apparatus comprising binders, sensitizers and reactants capable of undergoing rearrangements when exposed to actinic radiation causing optical changes such as refractive index EASTMAN KODAK COMPANY 2003-05-27 US disclosed
US-20030072250-A1 When exposed to actinic radiation produces a change in optical properties in the exposed region, contains a binder, a reactant capable of undergoing a transformation upon an electrone oxidation, and a sensitizer EASTMAN KODAK COMPANY 2003-04-17 US disclosed
EP-1246179-A2 Optical recording material EASTMAN KODAK COMPANY (US) 2002-10-02 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140296204-A1 CHEMICAL COMPOUNDS DNMT1, DNMT3A, DNMT3B FFAR1 4713/4885PTGDR2 3921/4885GRM5 2777/4885
US-20140012000-A1 PROCESS FOR PREPARING A PROPIOLIC ACID OR A DERIVATIVE THEREOF PCCA, C9, AOC3 FFAR1 3520/4885PTGDR2 666/4885GRM5 2472/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.